Industry perspectives on the MTD: growing acceptance in clinical development programs.
Chaikin
P
P
D002986:Clinical Trials as Topic; D004345:Drug Industry; D006801:Humans; D020714:Maximum Tolerated Dose; D009369:Neoplasms / Q000188:drug therapy